Protherics - Doc re Resolutions Passed at AGM
July 25 2008 - 11:57AM
Marketwired
Cheshire, UK , the international biopharmaceutical company
focused on critical care and cancer, has today forwarded for
publication through the Document Viewing Facility, copies of all
resolutions passed under Special business at the Company's Annual
General Meeting held on 22 July 2008 as summarised below: -
Approval of the Directors' Remuneration Report. - Renewal of
Directors' authority to allot shares. - Renewal of Directors'
authority to disapply pre-emption rights (in respect of up to 10
per cent. of the issued share capital of the Company). - Approval
of amendments to the Company's Articles of Association (the "New
Articles"). - Approval of the Protherics PLC 2008 Savings Related
Share Option Scheme ("Sharesave Scheme"). - Approval of amendment
to the Protherics PLC 1996 Unapproved Share Option Scheme
("Unapproved Scheme"). Copies of the full text of the above
Resolutions, together with copies of the New Articles, the rules of
the Sharesave Scheme and the amendment to the Unapproved Scheme can
be obtained from the United Kingdom Listing Authority's Document
Viewing Facility situated at the Financial Services Authority, The
North Colonnade, Canary Wharf, London E14 5HS. / Ends / For further
information please contact: Protherics Nick Staples, Director of
Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company
Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John
Capodanno +1 212 850 5600 Or visit www.protherics.com This
information is provided by RNS The company news service from the
London Stock Exchange END
Contacts: RNS Customer Services 0044-207797-4400 Email Contact
http://www.rns.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024
